In patients with hepatocellular carcinoma, TYRO3 expression was significantly associated with higher levels of serum and intratumoral alpha-fetoprotein [45,46], which is an independent diagnostic predictor of disease stage, disease progression, and poorer overall survival [126]. Here, AFP is linked to hepatocellular carcinoma.